147 related articles for article (PubMed ID: 16882106)
1. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease.
Chou SH; Chen YW; Chuang HY; Kao EL; Huang MF
J Clin Pharm Ther; 2006 Aug; 31(4):363-8. PubMed ID: 16882106
[TBL] [Abstract][Full Text] [Related]
2. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
[TBL] [Abstract][Full Text] [Related]
3. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype.
Lee JH; Lee YK; Kim EK; Kim TH; Huh JW; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Kim N; Seo JB; Oh YM; Lee SD
Respir Med; 2010 Apr; 104(4):542-9. PubMed ID: 19926461
[TBL] [Abstract][Full Text] [Related]
4. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
Kim WJ; Sheen SS; Kim TH; Huh JW; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Oh YM; Lee SD
Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659
[TBL] [Abstract][Full Text] [Related]
5. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
[TBL] [Abstract][Full Text] [Related]
6. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
[TBL] [Abstract][Full Text] [Related]
7. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study.
van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C
Am J Respir Crit Care Med; 2002 Nov; 166(10):1358-63. PubMed ID: 12406823
[TBL] [Abstract][Full Text] [Related]
8. Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
Umeda N; Yoshikawa T; Kanazawa H; Hirata K; Fujimoto S
Respirology; 2008 May; 13(3):346-52. PubMed ID: 18399855
[TBL] [Abstract][Full Text] [Related]
9. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P
Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
[TBL] [Abstract][Full Text] [Related]
10. Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD.
Sukisaki T; Senjyu H; Oishi K; Rikitomi N; Ariyoshi K
Physiother Theory Pract; 2008; 24(4):255-63. PubMed ID: 18574751
[TBL] [Abstract][Full Text] [Related]
11. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
12. The role of corticosteroids in chronic obstructive pulmonary disease.
Calverley PM
Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
14. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333
[TBL] [Abstract][Full Text] [Related]
15. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Lindberg A; Szalai Z; Pullerits T; Radeczky E
Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
[TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
Sin DD; Wu L; Anderson JA; Anthonisen NR; Buist AS; Burge PS; Calverley PM; Connett JE; Lindmark B; Pauwels RA; Postma DS; Soriano JB; Szafranski W; Vestbo J
Thorax; 2005 Dec; 60(12):992-7. PubMed ID: 16227327
[TBL] [Abstract][Full Text] [Related]
17. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
Walker PP; Calverley PM
COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
[TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
Pujades-RodrÃguez M; Smith CJ; Hubbard RB
QJM; 2007 Aug; 100(8):509-17. PubMed ID: 17609226
[TBL] [Abstract][Full Text] [Related]
20. Steroid therapy in chronic obstructive pulmonary disease.
OBrien A; Ward NS
Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
